Isoflavones & Lignans (so-called Phytoestrogens)
Urinary genistein
On this Page
Table 5.1.a. Urinary genistein: Total population
Geometric mean and selected percentiles of urine concentrations (in µg/L) for the total U.S. population aged 6 years and older, National Health and Nutrition Examination Survey, 1999–2002. |
|
Geometric mean
(95% conf. interval) |
Selected percentiles (95% conf. interval) |
Sample
size |
|
10th |
50th |
90th |
Males and Females |
Total, 6 years and older |
28.5 |
(25.5-31.8) |
3.27 |
(2.70-4.17) |
28.4 |
(25.7-30.7) |
293 |
(253-330) |
5351 |
6–11 years |
33.8 |
(29.3-39.1) |
5.80 |
(4.20-7.05) |
31.8 |
(25.2-37.3) |
248 |
(197-328) |
727 |
12–19 years |
38.0 |
(32.2-44.7) |
5.60 |
(4.00-8.20) |
34.8 |
(29.0-41.4) |
314 |
(249-365) |
1498 |
20–39 years |
31.3 |
(26.5-37.0) |
3.10 |
(2.40-4.80) |
29.0 |
(25.8-34.3) |
349 |
(269-437) |
1140 |
40–59 years |
23.7 |
(19.1-29.3) |
2.22 |
(.900-3.40) |
24.4 |
(21.3-29.4) |
298 |
(202-402) |
951 |
60 years and older |
24.1 |
(20.8-28.0) |
2.90 |
(2.20-3.95) |
24.2 |
(20.3-29.8) |
227 |
(155-308) |
1035 |
Males |
Total, 6 years and older |
31.1 |
(26.8-36.2) |
3.86 |
(3.10-5.20) |
30.3 |
(27.6-34.0) |
298 |
(235-341) |
2597 |
6–11 years |
34.6 |
(27.6-43.3) |
5.36 |
(3.30-7.04) |
35.2 |
(24.3-51.0) |
218 |
(146-348) |
368 |
12–19 years |
36.3 |
(28.1-46.8) |
6.21 |
(2.62-10.6) |
31.0 |
(25.6-41.4) |
299 |
(204-363) |
736 |
20–39 years |
33.5 |
(26.5-42.3) |
3.16 |
(2.30-5.39) |
30.7 |
(26.8-35.9) |
385 |
(245-522) |
500 |
40–59 years |
26.5 |
(19.7-35.6) |
3.35 |
(1.32-5.60) |
28.4 |
(20.1-35.7) |
281 |
(195-383) |
480 |
60 years and older |
29.8 |
(24.4-36.6) |
4.17 |
(3.10-5.73) |
31.1 |
(23.7-36.6) |
233 |
(141-335) |
513 |
Females |
Total, 6 years and older |
26.1 |
(23.7-28.8) |
2.85 |
(2.22-3.83) |
25.6 |
(23.5-28.4) |
285 |
(242-353) |
2754 |
6–11 years |
33.1 |
(26.2-41.9) |
5.50 |
(3.75-7.84) |
27.0 |
(21.8-36.1) |
272 |
(197-426) |
359 |
12–19 years |
39.8 |
(34.0-46.7) |
5.52 |
(4.00-8.40) |
36.8 |
(31.3-46.3) |
321 |
(247-445) |
762 |
20–39 years |
29.3 |
(24.0-35.8) |
2.99 |
(1.95-4.86) |
27.6 |
(22.5-36.3) |
312 |
(217-461) |
640 |
40–59 years |
21.2 |
(17.3-26.1) |
1.60 |
(<LOD-3.00) |
22.8 |
(18.7-26.0) |
327 |
(194-495) |
471 |
60 years and older |
20.5 |
(17.3-24.3) |
2.50 |
(1.26-3.51) |
20.3 |
(16.4-25.3) |
190 |
(129-290) |
522 |
< LOD means less than the limit of detection, which may vary for some compounds by year. See Appendix D for LOD. |
Table 5.1.b. Urinary genistein: Mexican Americans
Geometric mean and selected percentiles of urine concentrations (in µg/L) for Mexican Americans in the U.S. population aged 6 years and older, National Health and Nutrition Examination Survey, 1999–2002. |
|
Geometric mean
(95% conf. interval) |
Selected percentiles (95% conf. interval) |
Sample
size |
|
10th |
50th |
90th |
Males and Females |
Total, 6 years and older |
29.7 |
(25.4-34.8) |
4.07 |
(3.40-4.60) |
27.4 |
(23.5-32.5) |
294 |
(216-328) |
1498 |
6–11 years |
37.5 |
(26.3-53.4) |
3.78 |
(1.64-6.00) |
42.6 |
(22.7-63.5) |
432 |
(220-671) |
226 |
12–19 years |
32.4 |
(26.6-39.4) |
3.80 |
(2.50-5.40) |
34.2 |
(27.7-41.1) |
314 |
(216-367) |
543 |
20–39 years |
30.7 |
(22.8-41.3) |
4.50 |
(3.40-5.70) |
25.8 |
(18.5-37.5) |
302 |
(201-427) |
301 |
40–59 years |
24.8 |
(19.7-31.1) |
3.60 |
(2.08-5.62) |
25.7 |
(18.5-34.4) |
168 |
(106-286) |
221 |
60 years and older |
20.3 |
(16.5-25.0) |
2.48 |
(1.06-4.07) |
19.0 |
(13.7-31.1) |
190 |
(113-489) |
207 |
Males |
Total, 6 years and older |
33.6 |
(26.0-43.4) |
4.28 |
(3.10-5.40) |
31.6 |
(24.1-45.0) |
324 |
(294-432) |
724 |
6–11 years |
37.7 |
(23.6-60.3) |
3.30 |
(1.40-7.80) |
42.8 |
(22.4-63.5) |
341 |
(172-830) |
117 |
12–19 years |
34.0 |
(26.5-43.7) |
3.67 |
(2.09-5.70) |
39.7 |
(26.4-54.2) |
324 |
(216-373) |
276 |
20–39 years |
37.3 |
(23.9-58.2) |
4.50 |
(2.70-7.05) |
32.3 |
(19.1-72.9) |
406 |
(244-514) |
127 |
40–59 years |
28.7 |
(20.9-39.4) |
4.40† |
(2.80-8.30) |
29.0 |
(19.5-38.9) |
205† |
(97.3-540) |
105 |
60 years and older |
19.1 |
(12.5-29.4) |
2.48† |
(<LOD-6.30) |
16.9 |
(11.2-31.1) |
125† |
(57.0-614) |
99 |
Females |
Total, 6 years and older |
26.0 |
(23.0-29.4) |
3.80 |
(3.18-4.38) |
24.4 |
(20.7-26.9) |
220 |
(193-309) |
774 |
6–11 years |
37.2 |
(23.9-57.8) |
4.60† |
(<LOD-7.20) |
27.4 |
(19.3-84.7) |
523† |
(220-813) |
109 |
12–19 years |
30.6 |
(23.4-40.1) |
3.94 |
(2.00-6.11) |
30.2 |
(25.0-38.1) |
267 |
(166-492) |
267 |
20–39 years |
24.3 |
(19.0-31.2) |
4.32 |
(3.18-6.30) |
20.0 |
(14.6-26.9) |
215 |
(125-349) |
174 |
40–59 years |
21.3 |
(15.8-28.6) |
2.95 |
(<LOD-5.62) |
24.2 |
(17.0-34.4) |
146 |
(87.3-286) |
116 |
60 years and older |
21.4 |
(14.9-30.6) |
1.90† |
(<LOD-3.80) |
23.5 |
(10.9-38.9) |
213† |
(128-489) |
108 |
< LOD means less than the limit of detection, which may vary for some compounds by year. See Appendix D for LOD.
† Estimate is subject to greater uncertainty due to small cell size. |
Table 5.1.c. Urinary genistein: Non-Hispanic blacks
Geometric mean and selected percentiles of urine concentrations (in µg/L) for non-Hispanic blacks in the U.S. population aged 6 years and older, National Health and Nutrition Examination Survey, 1999–2002. |
|
Geometric mean
(95% conf. interval) |
Selected percentiles (95% conf. interval) |
Sample
size |
|
10th |
50th |
90th |
Males and Females |
Total, 6 years and older |
31.5 |
(25.2-39.3) |
3.73 |
(2.40-5.00) |
33.2 |
(26.8-41.5) |
328 |
(237-393) |
1289 |
6–11 years |
42.3 |
(32.8-54.4) |
4.70 |
(3.50-6.90) |
43.7 |
(32.4-58.0) |
417 |
(272-600) |
249 |
12–19 years |
46.7 |
(37.7-57.9) |
7.20 |
(5.84-10.0) |
39.5 |
(34.4-48.0) |
378 |
(306-467) |
451 |
20–39 years |
31.7 |
(22.9-43.8) |
3.70 |
(1.60-6.30) |
34.9 |
(25.4-49.1) |
301 |
(164-474) |
197 |
40–59 years |
24.3 |
(16.3-36.4) |
1.90 |
(<LOD-5.20) |
27.9 |
(18.5-39.7) |
246 |
(114-402) |
210 |
60 years and older |
24.6 |
(16.8-36.0) |
2.79 |
(1.20-5.40) |
23.7 |
(15.4-34.7) |
228 |
(137-641) |
182 |
Males |
Total, 6 years and older |
33.5 |
(24.7-45.6) |
4.60 |
(2.30-7.21) |
36.9 |
(28.8-49.1) |
257 |
(178-388) |
628 |
6–11 years |
45.0 |
(31.5-64.5) |
4.96 |
(3.33-7.05) |
49.6 |
(34.6-73.9) |
387 |
(205-687) |
127 |
12–19 years |
45.8 |
(36.6-57.4) |
7.00 |
(4.72-10.2) |
43.0 |
(34.6-56.7) |
334 |
(227-445) |
212 |
20–39 years |
30.2 |
(18.1-50.6) |
3.80† |
(<LOD-8.30) |
41.5 |
(24.0-57.2) |
252† |
(104-513) |
91 |
40–59 years |
26.7 |
(16.3-44.0) |
3.70† |
(<LOD-10.0) |
30.1 |
(16.6-50.4) |
178† |
(87.4-367) |
109 |
60 years and older |
33.2 |
(18.3-60.1) |
4.70† |
(<LOD-7.96) |
30.3 |
(15.9-58.6) |
276† |
(108-1120) |
89 |
Females |
Total, 6 years and older |
29.8 |
(24.0-37.1) |
3.00 |
(2.10-4.40) |
30.3 |
(23.3-38.2) |
363 |
(245-472) |
661 |
6–11 years |
39.4 |
(29.0-53.6) |
4.74 |
(1.70-9.70) |
34.5 |
(24.7-50.8) |
432 |
(203-600) |
122 |
12–19 years |
47.7 |
(35.9-63.4) |
7.54 |
(5.90-11.2) |
37.4 |
(29.6-47.6) |
394 |
(233-717) |
239 |
20–39 years |
32.8 |
(22.5-47.8) |
2.99† |
(<LOD-8.40) |
34.4 |
(21.0-50.7) |
346† |
(161-577) |
106 |
40–59 years |
22.4 |
(14.0-35.9) |
1.50† |
(<LOD-4.40) |
23.3 |
(17.1-38.6) |
285† |
(106-495) |
101 |
60 years and older |
20.2 |
(13.1-31.1) |
2.30† |
(<LOD-5.42) |
17.4 |
(10.6-33.3) |
228† |
(105-641) |
93 |
< LOD means less than the limit of detection, which may vary for some compounds by year. See Appendix D for LOD.
† Estimate is subject to greater uncertainty due to small cell size. |
Table 5.1.d. Urinary genistein: Non-Hispanic whites
Geometric mean and selected percentiles of urine concentrations (in µg/L) for non-Hispanic whites in the U.S. population aged 6 years and older, National Health and Nutrition Examination Survey, 1999–2002. |
|
Geometric mean
(95% conf. interval) |
Selected percentiles (95% conf. interval) |
Sample
size |
|
10th |
50th |
90th |
Males and Females |
Total, 6 years and older |
27.1 |
(24.2-30.4) |
2.96 |
(2.40-3.91) |
26.5 |
(23.9-29.5) |
281 |
(238-330) |
2112 |
6–11 years |
31.3 |
(25.2-38.9) |
6.40 |
(4.20-8.15) |
28.4 |
(22.4-37.3) |
217 |
(155-272) |
196 |
12–19 years |
36.4 |
(29.3-45.3) |
5.10 |
(3.30-9.70) |
33.3 |
(27.9-41.0) |
257 |
(209-331) |
375 |
20–39 years |
30.5 |
(24.0-38.7) |
2.80 |
(1.92-4.86) |
27.9 |
(23.7-34.0) |
387 |
(254-537) |
529 |
40–59 years |
23.9 |
(18.6-30.6) |
2.14 |
(<LOD-3.40) |
24.3 |
(19.7-29.5) |
335 |
(214-466) |
434 |
60 years and older |
22.2 |
(19.0-26.0) |
2.74 |
(1.71-3.98) |
22.5 |
(18.7-27.9) |
182 |
(129-282) |
578 |
Males |
Total, 6 years and older |
30.6 |
(26.1-35.9) |
3.90 |
(2.80-5.60) |
29.5 |
(26.5-33.1) |
293 |
(226-371) |
1038 |
6–11 years |
31.0 |
(22.9-42.0) |
6.20† |
(3.10-8.15) |
32.9 |
(20.6-48.3) |
190† |
(104-257) |
101 |
12–19 years |
33.2 |
(22.9-48.1) |
5.09 |
(2.20-11.5) |
28.3 |
(22.8-38.8) |
238 |
(141-371) |
190 |
20–39 years |
32.2 |
(23.7-43.8) |
2.90 |
(1.90-5.91) |
27.9 |
(23.7-34.3) |
413 |
(229-734) |
231 |
40–59 years |
29.1 |
(21.7-39.1) |
3.42 |
(1.32-5.85) |
28.7 |
(21.7-38.7) |
298 |
(195-447) |
225 |
60 years and older |
28.9 |
(23.0-36.4) |
4.17 |
(3.10-6.00) |
29.8 |
(21.9-36.7) |
229 |
(129-335) |
291 |
Females |
Total, 6 years and older |
24.1 |
(21.6-27.0) |
2.59 |
(1.50-3.20) |
23.7 |
(20.9-26.1) |
268 |
(226-353) |
1074 |
6–11 years |
31.7 |
(21.7-46.3) |
6.89† |
(3.51-10.2) |
26.7 |
(17.3-37.9) |
256† |
(131-500) |
95 |
12–19 years |
40.4 |
(33.6-48.6) |
5.10 |
(3.51-9.13) |
37.8 |
(29.0-53.2) |
305 |
(212-446) |
185 |
20–39 years |
28.9 |
(21.6-38.8) |
2.59 |
(1.40-4.90) |
27.0 |
(18.7-39.0) |
330 |
(206-626) |
298 |
40–59 years |
19.6 |
(14.5-26.6) |
.960 |
(<LOD-2.87) |
18.7 |
(14.3-24.9) |
355 |
(174-627) |
209 |
60 years and older |
18.1 |
(14.8-22.1) |
2.20 |
(1.00-3.75) |
18.4 |
(14.1-24.3) |
136 |
(118-202) |
287 |
< LOD means less than the limit of detection, which may vary for some compounds by year. See Appendix D for LOD.
† Estimate is subject to greater uncertainty due to small cell size. |
Urinary genistein (creatinine corrected)
Table 5.1.e. Urinary genistein: Total population (creatinine corrected)
Geometric mean and selected percentiles of urine concentrations (in µg/g creatinine) for the total U.S. population aged 6 years and older, National Health and Nutrition Examination Survey, 1999–2002. |
|
Geometric mean
(95% conf. interval) |
Selected percentiles (95% conf. interval) |
Sample
size |
|
10th |
50th |
90th |
Males and Females |
Total, 6 years and older |
26.6 |
(23.7-29.8) |
3.78 |
(3.08-4.46) |
24.8 |
(22.5-27.6) |
242 |
(209-274) |
5351 |
6–11 years |
36.7 |
(31.1-43.4) |
6.94 |
(5.22-8.13) |
34.9 |
(27.6-41.3) |
243 |
(186-292) |
727 |
12–19 years |
27.5 |
(23.3-32.4) |
4.36 |
(3.68-5.09) |
24.4 |
(20.9-30.8) |
192 |
(153-258) |
1498 |
20–39 years |
25.1 |
(21.5-29.2) |
3.77 |
(2.96-4.59) |
22.8 |
(19.1-26.3) |
244 |
(202-318) |
1140 |
40–59 years |
23.8 |
(19.3-29.3) |
2.48 |
(1.17-4.08) |
22.3 |
(18.5-28.7) |
270 |
(196-335) |
951 |
60 years and older |
28.9 |
(25.4-33.0) |
4.48 |
(3.17-5.31) |
26.6 |
(22.4-32.3) |
222 |
(175-285) |
1035 |
Males |
Total, 6 years and older |
25.0 |
(21.4-29.3) |
4.02 |
(3.25-4.74) |
23.0 |
(19.8-26.8) |
203 |
(177-265) |
2597 |
6–11 years |
36.5 |
(28.4-46.8) |
6.65 |
(4.52-8.13) |
35.4 |
(27.1-50.3) |
200 |
(154-286) |
368 |
12–19 years |
25.8 |
(20.4-32.5) |
4.23 |
(3.54-5.09) |
22.2 |
(18.6-31.7) |
164 |
(115-264) |
736 |
20–39 years |
23.3 |
(18.4-29.4) |
4.01 |
(1.99-5.04) |
19.0 |
(15.6-24.7) |
227 |
(170-330) |
500 |
40–59 years |
22.0 |
(16.1-30.0) |
3.21 |
(1.36-4.87) |
21.0 |
(16.1-30.9) |
222 |
(167-334) |
480 |
60 years and older |
28.0 |
(23.6-33.2) |
4.74 |
(3.44-6.19) |
27.1 |
(22.2-33.1) |
177 |
(143-324) |
513 |
Females |
Total, 6 years and older |
28.1 |
(25.3-31.3) |
3.50 |
(2.95-4.23) |
26.6 |
(23.8-29.7) |
265 |
(230-308) |
2754 |
6–11 years |
37.0 |
(28.2-48.6) |
7.69 |
(4.92-9.64) |
30.9 |
(21.9-47.9) |
255 |
(182-488) |
359 |
12–19 years |
29.3 |
(24.9-34.6) |
4.65 |
(3.09-6.00) |
28.2 |
(23.2-33.2) |
216 |
(162-304) |
762 |
20–39 years |
27.0 |
(22.4-32.5) |
3.32 |
(3.01-4.41) |
25.8 |
(21.1-30.3) |
265 |
(192-349) |
640 |
40–59 years |
25.6 |
(21.2-30.8) |
2.23 |
(<LOD-3.81) |
24.7 |
(17.6-36.0) |
287 |
(230-381) |
471 |
60 years and older |
29.7 |
(24.8-35.5) |
4.27 |
(2.52-5.68) |
26.6 |
(21.6-35.0) |
252 |
(191-319) |
522 |
< LOD means less than the limit of detection for the uncorrected urine value, which may vary for some compounds by year. See Appendix D for LOD. |
Table 5.1.f. Urinary genistein: Mexican Americans (creatinine corrected)
Geometric mean and selected percentiles of urine concentrations (in µg/g creatinine) for Mexican Americans in the U.S. population aged 6 years and older, National Health and Nutrition Examination Survey, 1999–2002. |
|
Geometric mean
(95% conf. interval) |
Selected percentiles (95% conf. interval) |
Sample
size |
|
10th |
50th |
90th |
Males and Females |
Total, 6 years and older |
27.6 |
(24.1-31.6) |
3.85 |
(3.35-4.65) |
24.5 |
(19.7-30.0) |
243 |
(208-279) |
1498 |
6–11 years |
48.0 |
(37.4-61.6) |
5.98 |
(3.95-8.12) |
42.4 |
(31.7-62.9) |
601 |
(317-717) |
226 |
12–19 years |
25.5 |
(21.4-30.4) |
3.42 |
(2.96-4.23) |
24.6 |
(19.7-31.7) |
188 |
(165-254) |
543 |
20–39 years |
25.3 |
(19.5-32.9) |
3.79 |
(3.16-5.11) |
19.1 |
(14.8-32.6) |
215 |
(181-257) |
301 |
40–59 years |
24.8 |
(19.9-31.0) |
4.01 |
(2.88-5.44) |
25.6 |
(18.6-32.8) |
176 |
(124-279) |
221 |
60 years and older |
23.4 |
(18.4-29.6) |
3.49 |
(1.13-5.08) |
22.1 |
(15.8-35.0) |
216 |
(142-329) |
207 |
Males |
Total, 6 years and older |
27.7 |
(22.5-34.1) |
4.01 |
(3.10-5.17) |
25.7 |
(18.7-34.9) |
228 |
(190-285) |
724 |
6–11 years |
45.3 |
(30.6-66.9) |
4.29 |
(2.85-9.69) |
40.7 |
(29.1-66.8) |
627 |
(206-776) |
117 |
12–19 years |
25.6 |
(20.3-32.3) |
3.62 |
(2.22-4.66) |
24.7 |
(18.3-40.4) |
185 |
(165-270) |
276 |
20–39 years |
27.5 |
(18.7-40.3) |
3.99 |
(2.72-5.71) |
19.8 |
(13.5-41.2) |
226 |
(180-323) |
127 |
40–59 years |
24.1 |
(17.7-32.8) |
4.91† |
(3.21-6.44) |
25.6 |
(14.8-34.3) |
159† |
(96.9-335) |
105 |
60 years and older |
18.0 |
(12.2-26.6) |
3.05† |
(<LOD-5.74) |
18.5 |
(10.8-32.4) |
135† |
(50.5-292) |
99 |
Females |
Total, 6 years and older |
27.5 |
(24.0-31.4) |
3.72 |
(3.27-4.42) |
23.8 |
(19.2-26.2) |
253 |
(195-324) |
774 |
6–11 years |
51.0 |
(37.5-69.4) |
7.40† |
(<LOD-9.57) |
44.0 |
(25.1-94.3) |
537† |
(253-926) |
109 |
12–19 years |
25.5 |
(19.4-33.4) |
3.42 |
(2.71-4.65) |
24.5 |
(16.1-36.3) |
195 |
(131-313) |
267 |
20–39 years |
23.0 |
(18.2-29.1) |
3.60 |
(3.20-4.61) |
16.8 |
(13.8-25.5) |
205 |
(119-325) |
174 |
40–59 years |
25.6 |
(19.8-33.2) |
3.17 |
(<LOD-5.96) |
24.4 |
(17.5-33.6) |
219 |
(121-324) |
116 |
60 years and older |
29.0 |
(19.9-42.2) |
3.50† |
(<LOD-11.2) |
27.9 |
(14.7-59.2) |
237† |
(142-408) |
108 |
< LOD means less than the limit of detection for the uncorrected urine value, which may vary for some compounds by year. See Appendix D for LOD.
† Estimate is subject to greater uncertainty due to small cell size. |
Table 5.1.g. Urinary genistein: Non-Hispanic blacks (creatinine corrected)
Geometric mean and selected percentiles of urine concentrations (in µg/g creatinine) for non-Hispanic blacks in the U.S. population aged 6 years and older, National Health and Nutrition Examination Survey, 1999–2002. |
|
Geometric mean
(95% conf. interval) |
Selected percentiles (95% conf. interval) |
Sample
size |
|
10th |
50th |
90th |
Males and Females |
Total, 6 years and older |
21.2 |
(17.0-26.4) |
3.24 |
(2.52-4.26) |
21.1 |
(17.2-26.1) |
192 |
(154-239) |
1289 |
6–11 years |
39.5 |
(31.0-50.4) |
5.59 |
(3.92-9.81) |
38.5 |
(28.9-51.2) |
279 |
(203-409) |
249 |
12–19 years |
26.2 |
(21.4-32.1) |
4.25 |
(3.54-5.18) |
24.9 |
(20.0-30.8) |
224 |
(138-351) |
451 |
20–39 years |
18.0 |
(12.8-25.3) |
2.82 |
(.344-4.26) |
19.0 |
(13.4-25.6) |
186 |
(95.1-281) |
197 |
40–59 years |
16.4 |
(11.4-23.7) |
2.56 |
(<LOD-4.68) |
16.4 |
(11.5-23.7) |
152 |
(101-217) |
210 |
60 years and older |
23.1 |
(17.0-31.5) |
4.13 |
(2.22-5.31) |
20.9 |
(14.9-30.9) |
178 |
(106-384) |
182 |
Males |
Total, 6 years and older |
20.3 |
(15.1-27.3) |
3.24 |
(1.99-4.68) |
20.7 |
(16.4-28.5) |
162 |
(109-222) |
628 |
6–11 years |
41.8 |
(29.2-59.7) |
5.47 |
(3.10-12.9) |
41.3 |
(28.5-71.2) |
274 |
(165-450) |
127 |
12–19 years |
25.0 |
(20.1-31.0) |
3.12 |
(1.84-5.01) |
26.1 |
(20.0-34.8) |
176 |
(114-260) |
212 |
20–39 years |
14.7 |
(8.72-24.7) |
2.82† |
(<LOD-5.12) |
17.2 |
(10.1-25.6) |
103† |
(53.9-191) |
91 |
40–59 years |
16.3 |
(10.0-26.5) |
2.56† |
(<LOD-5.14) |
18.7 |
(10.4-30.4) |
112† |
(49.6-236) |
109 |
60 years and older |
24.7 |
(14.3-42.4) |
4.86† |
(<LOD-7.14) |
20.4 |
(14.7-32.8) |
322† |
(74.5-783) |
89 |
Females |
Total, 6 years and older |
22.1 |
(17.9-27.1) |
3.33 |
(2.58-4.15) |
21.6 |
(16.5-26.9) |
224 |
(159-317) |
661 |
6–11 years |
37.3 |
(28.2-49.4) |
5.59 |
(2.77-9.59) |
31.6 |
(21.3-54.0) |
344 |
(185-462) |
122 |
12–19 years |
27.6 |
(21.0-36.2) |
5.14 |
(4.13-6.43) |
22.9 |
(16.6-32.3) |
261 |
(130-460) |
239 |
20–39 years |
21.2 |
(14.5-31.1) |
3.01† |
(<LOD-5.56) |
23.3 |
(13.5-30.3) |
247† |
(140-415) |
106 |
40–59 years |
16.5 |
(10.9-25.0) |
2.22† |
(<LOD-4.89) |
14.3 |
(10.6-25.0) |
154† |
(109-247) |
101 |
60 years and older |
22.1 |
(15.5-31.6) |
3.95† |
(<LOD-5.45) |
20.0 |
(13.1-33.8) |
178† |
(90.2-446) |
93 |
< LOD means less than the limit of detection for the uncorrected urine value, which may vary for some compounds by year. See Appendix D for LOD.
† Estimate is subject to greater uncertainty due to small cell size. |
Table 5.1.h. Urinary genistein: Non-Hispanic whites (creatinine corrected)
Geometric mean and selected percentiles of urine concentrations (in µg/g creatinine) for non-Hispanic whites in the U.S. population aged 6 years and older, National Health and Nutrition Examination Survey, 1999–2002. |
|
Geometric mean
(95% conf. interval) |
Selected percentiles (95% conf. interval) |
Sample
size |
|
10th |
50th |
90th |
Males and Females |
Total, 6 years and older |
27.0 |
(24.1-30.2) |
3.80 |
(2.98-4.66) |
25.6 |
(22.7-28.8) |
242 |
(207-284) |
2112 |
6–11 years |
34.0 |
(26.7-43.3) |
7.20 |
(4.92-10.4) |
31.7 |
(23.3-40.8) |
186 |
(145-279) |
196 |
12–19 years |
27.6 |
(22.0-34.7) |
4.76 |
(2.77-6.72) |
24.1 |
(20.6-33.0) |
166 |
(130-232) |
375 |
20–39 years |
26.6 |
(21.7-32.5) |
3.89 |
(2.96-4.86) |
24.4 |
(17.5-31.5) |
268 |
(208-348) |
529 |
40–59 years |
25.0 |
(19.6-31.9) |
2.47 |
(<LOD-4.07) |
24.2 |
(18.1-33.2) |
287 |
(204-367) |
434 |
60 years and older |
27.7 |
(24.4-31.4) |
4.63 |
(2.98-6.09) |
26.0 |
(21.9-32.0) |
185 |
(150-274) |
578 |
Males |
Total, 6 years and older |
25.9 |
(22.1-30.4) |
4.35 |
(3.66-5.13) |
24.6 |
(20.6-29.3) |
196 |
(169-284) |
1038 |
6–11 years |
34.1 |
(24.7-47.1) |
6.08† |
(2.28-11.9) |
35.3 |
(18.9-60.1) |
168† |
(115-279) |
101 |
12–19 years |
25.2 |
(17.9-35.5) |
4.35 |
(2.76-6.73) |
21.0 |
(17.0-29.6) |
124 |
(95.4-264) |
190 |
20–39 years |
24.5 |
(18.3-32.7) |
4.48 |
(1.42-5.71) |
19.5 |
(14.8-28.4) |
246 |
(170-365) |
231 |
40–59 years |
24.5 |
(17.9-33.5) |
3.32 |
(1.55-5.13) |
22.0 |
(16.3-35.8) |
271 |
(167-379) |
225 |
60 years and older |
27.6 |
(23.4-32.7) |
4.85 |
(3.73-6.59) |
26.8 |
(20.5-34.3) |
170 |
(111-285) |
291 |
Females |
Total, 6 years and older |
28.1 |
(25.0-31.6) |
3.16 |
(2.45-4.27) |
26.6 |
(22.5-31.3) |
274 |
(230-323) |
1074 |
6–11 years |
33.9 |
(22.4-51.4) |
7.69† |
(4.25-11.6) |
27.6 |
(17.4-41.1) |
200† |
(140-571) |
95 |
12–19 years |
30.5 |
(24.3-38.4) |
4.74 |
(2.59-7.08) |
29.8 |
(21.7-40.1) |
203 |
(141-304) |
185 |
20–39 years |
28.8 |
(22.6-36.7) |
3.20 |
(2.63-4.86) |
27.0 |
(19.6-37.3) |
283 |
(206-357) |
298 |
40–59 years |
25.5 |
(19.2-34.0) |
1.62 |
(<LOD-4.07) |
24.2 |
(15.6-40.4) |
323 |
(220-480) |
209 |
60 years and older |
27.8 |
(22.5-34.2) |
4.27 |
(2.00-6.44) |
25.9 |
(19.9-35.0) |
222 |
(155-319) |
287 |
< LOD means less than the limit of detection for the uncorrected urine value, which may vary for some compounds by year. See Appendix D for LOD.
† Estimate is subject to greater uncertainty due to small cell size. |